Seeq Corporation

Seeq Corporation provides industrial analytics and AI-powered software for process manufacturing industries, serving 50% of the top global pharmaceutical companies and 30% of the top CDMOs. Founded in 2013 by Steve Sliwa, Brian Parsonnet, Jon Peterson, and Mark Derbecker, Seeq enables engineers and data scientists to rapidly investigate and share insights from time-series data across oil & gas, chemicals, pharmaceuticals, utilities, mining, food & beverage, and semiconductors.

The company's flagship product, Seeq Workbench, provides advanced analytics capabilities including machine learning tools (Self-Organizing Maps, Isolation Forest, Partial Least Squares), an AI Assistant for natural language queries, and enterprise monitoring capabilities. In Q1 2025, Seeq launched a pharma-specific variant - Seeq for Pharma Analytics & AI Suite - designed with enhanced GxP compliance and validation support for 21 CFR Part 11 requirements.

Headquartered in Seattle, Washington, Seeq operates with a fully remote global team of 200+ employees distributed across North America, Europe, Asia, and South America. The company serves hundreds of customers in 36 countries, including 50% of the top global pharmaceutical companies and 30% of the top CDMOs. Named pharma customers include Bristol-Myers Squibb, Sanofi, Eli Lilly, Regeneron, Abbott Nutrition, Pfizer, Amgen, and Merck.

Seeq has raised $165M in total funding across 10 rounds, most recently completing a $50M Series D round in August 2024 led by Sixth Street Growth with participation from Insight Partners, Altira Group, Second Avenue Partners, and Saudi Aramco Energy Ventures. The company remains privately held and independent, led by CEO Dr. Lisa Graham with founder Steve Sliwa still actively involved.

Seeq is a multi-industry industrial analytics platform serving pharmaceuticals alongside oil & gas, chemicals, utilities, mining, food & beverage, and semiconductors. Per the vendor, 50% of top global pharmaceutical companies and 30% of top CDMOs use Seeq's platform. In Q1 2025 Seeq launched a pharma-specific product variant, Seeq for Pharma Analytics & AI Suite, built for pharmaceutical manufacturing with GxP compliance capabilities and validation support for 21 CFR Part 11 requirements.

Total customer count across all industries is in the "hundreds," per the company's Series D press release, with customers in 36 countries. Exact pharma customer count and the percentage of total customers that are pharma are undisclosed. Named pharmaceutical customers: Bristol-Myers Squibb, Sanofi, Eli Lilly, Regeneron, Abbott Nutrition, Pfizer, Amgen, and Merck. The company serves Big Pharma companies, biotech firms, and CDMOs. Medical device and generic-drug manufacturer coverage is unstated.

Seeq publishes validation guidelines and compliance guidance for GMP and 21 CFR Part 11. FDA inspection pass rates are undisclosed. Conneqt, the company's annual user conference, runs a pharmaceutical track, and Seeq maintains a dedicated pharma solutions page.

$165M in total funding across 10 rounds; some sources report $198M. The most recent round was $50M Series D funding, announced August 6, 2024 and led by Sixth Street Growth with participation from existing investors. Nari Ansari, Managing Director at Sixth Street Growth, joined the board as part of the round. A $55.8M Series C round closed in April 2021, led by Insight Partners. Other named investors: Altira Group, Second Avenue Partners, and Saudi Aramco Energy Ventures.

Enterprise value is estimated at $535M by Dealroom.co. Revenue, profitability, and cash flow are undisclosed. No acquisition in the last three years; the company remains independent.

Four products: Seeq Workbench (flagship), Seeq Organizer, Seeq Data Lab, and Seeq for Pharma Analytics & AI Suite, launched Q1 2025. The portfolio spans Industrial Analytics, AI-driven Insights, Enterprise Monitoring, and Process Manufacturing Analytics categories.

Seeq Workbench is the core analytics application for engineers and data scientists, with the Seeq AI Assistant for natural language queries and machine learning tools — Self-Organizing Maps, Isolation Forest, and Partial Least Squares — for predictive analytics. The platform is sold both as a suite (the bundled Industrial Analytics & AI Suite, with a pharma-specific variant) and modularly, with user tiers (Pro, Standard, Light) and separate components (Workbench, Organizer, Data Lab) that deploy independently.

The platform is cloud-native, with SaaS as the primary deployment option on AWS and Azure. Seeq is listed on both AWS Marketplace and Azure Marketplace (since 2019) and deploys in any AWS Availability Zone. It integrates with Azure Synapse, Azure Data Lake, Google BigQuery, SAP HANA, and Oracle databases. Mobile apps for iOS or Android are unstated. The platform is built for real-time time-series data analysis for process optimization, quality improvement, and operational intelligence across manufacturing operations.

Seeq holds partnerships with major cloud and technology providers. The company is a Microsoft Azure partner, listed in Azure Marketplace since 2019, supporting Azure Synapse, Azure Data Lake, and Active Directory integration. Seeq is also an AWS partner, listed on AWS Marketplace and able to deploy in any AWS Availability Zone. Google Cloud is supported through a BigQuery data-source integration.

Enterprise data platform partnerships include SAP (connects to SAP HANA as a data source) and Oracle (connects to Oracle databases). No Salesforce partnership is stated. For implementation, Seeq names Enhanced Information Solutions, Inc. as an implementation partner; no other consulting or implementation partner is named.

ISPE membership and PQG (Parenteral Drug Association Quality Group) membership are unstated. No FDA partnership or direct collaboration is stated.

Support and professional services run through the Seeq Success Plan, required with every license. The support team is distributed across North America, Europe, Asia, and South America. 24/7 support availability is unstated. Support languages are unspecified.

The primary support contact is [email protected], as listed on AWS Marketplace; no dedicated support phone number is stated. Live chat availability is unstated. A Seeq Knowledge Base at support.seeq.com covers self-service support, training, and documentation.

Professional services include implementation (through the Seeq Success Plan), validation for pharma customers (Validation Guidelines for 21 CFR Part 11 and GMP compliance), training through the Knowledge Base and potentially instructor-led options, and consulting available directly through Seeq and through its partner network.

Seeq holds an annual user conference, Conneqt; the 2025 edition featured a dedicated pharmaceuticals track. User community forums are unstated. No certification program is stated. The resource center at seeq.com/resources includes whitepapers, webinars, case studies, and videos for ongoing customer education.

G2 named Seeq Best Software in the UK for 2025. Verdantix named it a Green Quadrant Industrial AI Analytics Leader, citing strengths in data contextualization, process optimization, and ML development. The company has reviews on Gartner Peer Insights but is not included in an official Gartner Magic Quadrant. No Forrester recognition is stated.

ISO 9001, ISO 27001, and SOC 2 status are unstated. The SaaS architecture runs on AWS and Azure.

Leadership: CEO Dr. Lisa Graham, who leads the company's scaling, with founder Steve Sliwa still actively involved (11+ years since the company's 2013 founding). No CTO is named. Board member Nari Ansari (Managing Director, Sixth Street Growth) joined as part of the 2024 Series D round.

Seeq publishes an active blog at seeq.com/resources/blog/ with industry insights and technical content, whitepapers and technical documentation in the resources section, and regular webinars and recorded presentations. The company has a presence in the process manufacturing analytics community through speaking engagements at industry events and the annual Conneqt user conference.

Website copyright is 2025, last modified October 2025, with press-release activity approximately quarterly. The most recent press release, dated August 6, 2024, announced the $50M Series D funding. A dedicated newsroom is available at seeq.com/resources/press-releases/.

Seeq holds an active LinkedIn company page (linkedin.com/company/seeqcorporation); follower count is not accessible without a LinkedIn login. No Twitter/X handle is stated. LinkedIn is the primary channel for B2B engagement and thought leadership.

The resource center at seeq.com/resources/ features blog articles, videos, case studies, whitepapers, and recorded webinars. Product demos are available through a "Request Demo" option on the website. Free trial availability is unstated.

The site loads quickly, uses a modern design, and returns no broken links. Navigation is organized by industry, by role, and by use case.